Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Varghese

Showing results (341-350 of 372) with videos related to

Pageof 38
Sort By:
NPJ Precision Oncology|February 7, 2026
Dual pancreatic carcinomas: clonally related or independent primaries?Joshua D Schoenfeld, Vignesh Ravichandran, Zeynep Tarcan, et al.
Cancer Cell|January 10, 2018
Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal CancerRona Yaeger, Walid K Chatila, Marla D Lipsyc, et al.
Nature|August 17, 2022
Ordered and deterministic cancer genome evolution after p53 lossTimour Baslan, John P Morris, Zhen Zhao, et al.
The New England Journal of Medicine|June 16, 2025
Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic LeukemiaTalha Munir, Sean Girvan, David A Cairns, et al.
Nature Medicine|January 3, 2025
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survivalAnna M Varghese, Maria A Perry, Joanne F Chou, et al.
Cancer Discovery|December 17, 2017
First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion StudyRyan J Sullivan, Jeffrey R Infante, Filip Janku, et al.
Infection|July 8, 2025
Bridging continents: postgraduate infectious diseases training programs from central Europe to Southeast AsiaSelcen Öncü, Hakan Erdem, Zeliha Kocak Tufan, et al.
Journal of the National Cancer Institute|October 26, 2024
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohortFergus Keane, Catherine O'Connor, Drew Moss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2020
Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment SelectionWungki Park, Jiapeng Chen, Joanne F Chou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2020
Mismatch Repair-Deficient Rectal Cancer and Resistance to Neoadjuvant ChemotherapyAndrea Cercek, Gustavo Dos Santos Fernandes, Campbell S Roxburgh, et al.
Pageof 38

Showing results (341-350 of 372) with videos related to

Sort By:
Pageof 38
NPJ Precision Oncology|February 7, 2026
Dual pancreatic carcinomas: clonally related or independent primaries?Joshua D Schoenfeld, Vignesh Ravichandran, Zeynep Tarcan, et al.
Cancer Cell|January 10, 2018
Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal CancerRona Yaeger, Walid K Chatila, Marla D Lipsyc, et al.
Nature|August 17, 2022
Ordered and deterministic cancer genome evolution after p53 lossTimour Baslan, John P Morris, Zhen Zhao, et al.
The New England Journal of Medicine|June 16, 2025
Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic LeukemiaTalha Munir, Sean Girvan, David A Cairns, et al.
Nature Medicine|January 3, 2025
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survivalAnna M Varghese, Maria A Perry, Joanne F Chou, et al.
Cancer Discovery|December 17, 2017
First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion StudyRyan J Sullivan, Jeffrey R Infante, Filip Janku, et al.
Infection|July 8, 2025
Bridging continents: postgraduate infectious diseases training programs from central Europe to Southeast AsiaSelcen Öncü, Hakan Erdem, Zeliha Kocak Tufan, et al.
Journal of the National Cancer Institute|October 26, 2024
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohortFergus Keane, Catherine O'Connor, Drew Moss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2020
Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment SelectionWungki Park, Jiapeng Chen, Joanne F Chou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2020
Mismatch Repair-Deficient Rectal Cancer and Resistance to Neoadjuvant ChemotherapyAndrea Cercek, Gustavo Dos Santos Fernandes, Campbell S Roxburgh, et al.
Pageof 38